CN1078902A - Treatment hepatitis B Chinese medicine - Google Patents
Treatment hepatitis B Chinese medicine Download PDFInfo
- Publication number
- CN1078902A CN1078902A CN 93105106 CN93105106A CN1078902A CN 1078902 A CN1078902 A CN 1078902A CN 93105106 CN93105106 CN 93105106 CN 93105106 A CN93105106 A CN 93105106A CN 1078902 A CN1078902 A CN 1078902A
- Authority
- CN
- China
- Prior art keywords
- gram
- hepatitis
- grams
- chinese medicine
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A kind of novel treatment hepatitis B Chinese medicine can be used for the medical treatment of hepatitis B and turning out cloudy of hepatitis B virus carriers.The objective of the invention is motherland's Chinese medicine theory specifically is applied in the treatment of hepatopathy, make liver treating medicine evident in efficacy.Its principal character is that it consists of: Fructus Forsythiae 14-16 gram, Fructus Gardeniae 14-16 gram, Radix Bupleuri 9-11 gram, Radix Salviae Miltiorrhizae 14-16 gram, Herba Artemisiae Scopariae 45-55 gram, Rhizoma Corydalis 14-16 gram, Rhizoma Atractylodis Macrocephalae 14-16 gram, Radix Astragali 18-22 gram, Radix Gentianae 24-26 gram.But this medicine eradication hepatitis b virus improves liver function, promotes hepatocyte to recover, and reduces hepatic fibrosis, reaches therapeutic purposes.
Description
A kind of novel treatment hepatitis B Chinese medicine composition or its extracts active ingredients compositions can be used for the medical treatment of hepatitis B and turning out cloudy of hepatitis B virus carriers.
Present domesticly still do not have special effect medicine with Chinese herbal treatment hepatitis B and carrier thereof.
The objective of the invention is motherland's Chinese medicine theory specifically is applied in the treatment of hepatopathy, make liver treating medicine evident in efficacy.
The present invention treats hepatitis B Chinese medicine, and its principal character is to consist of: connect and call 14-16 gram, Fructus Gardeniae 14-16 gram, CAIHU 9-11 gram, Radix Salviae Miltiorrhizae 14-16 gram, Herba Artemisiae Scopariae 45-55 gram, Rhizoma Corydalis 14-16 gram, Rhizoma Atractylodis Macrocephalae 14-16 gram, Radix Astragali 18-22 gram, Radix Gentianae 24-26 gram together.The Chinese medicine composition that said herbal medicine is formed can be made dosage forms such as decoction, pill, electuary or capsule, also can make compositions with its extracts active ingredients.
The present invention treats hepatitis B Chinese medicine, but heat-clearing and toxic substances removing, liver-smoothing, qi-regulating, invigorating spleen to remove dampness, blood circulation promoting and blood stasis dispelling, eradication hepatitis b virus, inhibition hepatitis B virus duplication and breeding improve liver function, promote hepatocyte to recover, and strengthen the human body immunity, reduce hepatic fibrosis, reach therapeutic purposes.Use through clinical 500 people, negative conversion rate 62%, treatment rate are 92%.Two months courses of treatment, prove effective two courses of treatment.
Model case:
Song Lin, man, 70 years old, retired veteran cadre, home address: the Road Inside Area, Harbin City altogether happy street * number, in June, 84 health check-up finds surface antigen positive, diagnosis: hepatitis B, the symptomless virus carrier, the doctor advises periodic review, on July 25th, 84, first visit comes the No.1 Hospital, Harbin City check.Surface antigen positive, no conscious sympton, liver spleen are little, on August 22nd, 84 went to a doctor in the No.1 Hospital, Harbin City department of Chinese medicine, take traditional Chinese medicine 60 pairs, chemical examination on November 25 is surface antigen positive as a result, and moving to city's first hospital's hepatitis patient on November 26 is inventor Zhou Yu associate chief physician diagnosis and treatment, takes 60 pairs of decoctions of the present invention, on March 14th, 85, surface antigen transferred feminine gender to, changed the clothes electuary for simplicity.April 18 chemically examined again, and the surface antigen feminine gender is still obeyed electuary later on.JIUYUE was done comprehensive antigen system chemical examination on the 5th in 85 years, and every index is normally, took continuously in order to consolidate curative effect, and is all negative through three antigen-antibody system chemical examinations in half a year.
Sheng Xianmei, woman, 45 years old, engineer, home address: No. 7, kobold street, Road Outside Area, Harbin City, phone are 494395
On March 20th, 84, the conscious hepatalgia in back of returning away on official business from south, general malaise, weak, detest oil, poor appetite.Go to a doctor to the No.1 Hospital, Harbin City and to have a medical check-up: sclera does not have yellow seven, heart (), and 1.0cm, matter under rib are soft for liver, and spleen does not touch.Result of laboratory test: liver transaminase 125, surface antigen positive, diagnosis: acute non-icteric type hepatitis B, once took in outpatient service: liver-protecting tablet, Fuganning, inosine sheet etc., sb.'s illness took a favorable turn.In May, 85, clinical symptoms increases the weight of, surface antigen positive, and once Ha Erbin city hospital for infectious disease hospitalization three months, liver power recovery was normal.Five indexes of hepatitis b chemical examination, surface antigen positive, the e antigen positive, core antibody positive, patient's No.1 Hospital, Harbin City Hepatitis Dept. that comes is gone to a doctor, and takes 120 pairs of decoctions of medicine of the present invention, electuary.In April, 87, result of laboratory test: surface antigen transfers feminine gender to, the surface antibody feminine gender, and the e antigen negative, the e antibody positive, the core antibody feminine gender, liver function is normal, clinical symptom disappearance.
After half a year, follow up a case by regular visits to: the clinical symptoms complete obiteration, liver function is normal, through health check-up, five five indexes of hepatitis b chemical examinations, surface antigen is negative always, e antigen negative, e antibody positive, core antibody feminine gender, not recurrence up to now.
Wang Binsheng, man, 50 years old, the patent department director of the Harbin City State Scientific and Technological Commission.Hepatitis b surface antigen positive appears in the health check-up of in February, 93 office, liver transaminase 60, and symptom is unable, hyperhidrosis, poor appetite, and outpatient service is decided to be hepatitis B.After taking 53 pairs of prescription decoctions of the present invention, symptom takes a turn for the better, and appetite increases, through the chemical examination five indexes of hepatitis b, and turning out cloudy property of surface antigen, surface antibody occurs positive, and the transaminase reduces, and drug effect is very remarkable.
The component of most preferred embodiment of the present invention is called 15 grams, Fructus Gardeniae 15 grams, CAIHU 10 grams, Radix Salviae Miltiorrhizae 15 grams, Herba Artemisiae Scopariae 50 grams, Rhizoma Corydalis 15 grams, the Rhizoma Atractylodis Macrocephalae 15 grams, the Radix Astragali 20 grams, Radix Gentianae 25 grams together for connecting.
Claims (3)
1, a kind of novel treatment hepatitis B Chinese medicine composition or its extracts active ingredients compositions is characterized in that: its company of consisting of calls 14-16 gram, Fructus Gardeniae 14-16 gram, CAIHU 9-11 gram, Radix Salviae Miltiorrhizae 14-16 gram, Herba Artemisiae Scopariae 45-55 gram, Rhizoma Corydalis 14-16 gram, Rhizoma Atractylodis Macrocephalae 14-16 gram, Radix Astragali 18-22 gram, Radix Gentianae 24-26 gram together.
2, treatment hepatitis B Chinese medicine composition according to claim 1 or its extracts active ingredients compositions is characterized in that: it form to connect, and to call together be 15 grams, Fructus Gardeniae 15 grams, CAIHU 10 grams, Radix Salviae Miltiorrhizae 15 grams, Herba Artemisiae Scopariae 50 grams, Rhizoma Corydalis 15 grams, the Rhizoma Atractylodis Macrocephalae 15 grams, the Radix Astragali 20 grams, Radix Gentianae 25 grams.
3, treatment hepatitis B Chinese medicine according to claim 1 and 2, it is characterized in that: it can be made into dosage forms such as decoction, pill, electuary or capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93105106 CN1078902A (en) | 1993-05-03 | 1993-05-03 | Treatment hepatitis B Chinese medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93105106 CN1078902A (en) | 1993-05-03 | 1993-05-03 | Treatment hepatitis B Chinese medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1078902A true CN1078902A (en) | 1993-12-01 |
Family
ID=4985554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 93105106 Pending CN1078902A (en) | 1993-05-03 | 1993-05-03 | Treatment hepatitis B Chinese medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1078902A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1059104C (en) * | 1996-09-27 | 2000-12-06 | 张庆兰 | Capsule for anti hepatitis B |
| CN1063951C (en) * | 1997-01-17 | 2001-04-04 | 湖南华盛生物技术有限公司 | Chinese patent drug for curing hepatitis |
| CN1899370B (en) * | 2006-07-01 | 2010-05-26 | 邓德刚 | Compound calyx melo extract tablet |
| CN109010511A (en) * | 2018-10-15 | 2018-12-18 | 山东迅达康兽药有限公司 | A kind of pharmaceutical composition and the preparation method and application thereof preventing and treating poultry hepatic injury |
-
1993
- 1993-05-03 CN CN 93105106 patent/CN1078902A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1059104C (en) * | 1996-09-27 | 2000-12-06 | 张庆兰 | Capsule for anti hepatitis B |
| CN1063951C (en) * | 1997-01-17 | 2001-04-04 | 湖南华盛生物技术有限公司 | Chinese patent drug for curing hepatitis |
| CN1899370B (en) * | 2006-07-01 | 2010-05-26 | 邓德刚 | Compound calyx melo extract tablet |
| CN109010511A (en) * | 2018-10-15 | 2018-12-18 | 山东迅达康兽药有限公司 | A kind of pharmaceutical composition and the preparation method and application thereof preventing and treating poultry hepatic injury |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102755594B (en) | Traditional Chinese medicine composition for treating acute and chronic hepatitis B and preparation method thereof | |
| CN102614440B (en) | Multi-herb antibacterial liquid | |
| CN104383055A (en) | Drug for treating end-stage liver diseases caused by chronic hepatitis B and preparation method of drug | |
| CN102552761A (en) | Chinese medicinal pills for treating psoriasis | |
| CN101766720B (en) | Medicine for treatment of liver disease | |
| CN1078902A (en) | Treatment hepatitis B Chinese medicine | |
| CN103989972A (en) | Chinese herbal medicine treating influenza and preparation method thereof | |
| CN102552512A (en) | Traditional Chinese medicine used for treating hepatitis B | |
| CN100579544C (en) | Chinese medicament preparation for treating cholecystitis and gall-stone as well as preparation method thereof | |
| CN1062479C (en) | Medicine for treating prostatosis and method for preparing same | |
| CN1233349C (en) | Traditional Chinese medicine composition for clearing fire, expelling toxin and eliminating swelling and application thereof | |
| CN101152481A (en) | Traditional Chinese medicine for treating recurrent oral ulcer | |
| CN104127827A (en) | Traditional Chinese medicine for treating biliary calculi | |
| CN100486631C (en) | Chinese traditional medicinal formula for treating AIDS | |
| CN1078897A (en) | " hepatitis B health " Chinese medicine preparation and preparation technology thereof | |
| CN1183986A (en) | Chinese medicine Pingguxiaociwan for curing Bi-syndrome | |
| CN103845689A (en) | External application medicine for treating benign prostatic hyperplasia | |
| CN103272183B (en) | Traditional Chinese medicine for treating hepatitis B induced cirrhosis | |
| CN101721652A (en) | Medicine for treating liver diseases and production method thereof | |
| CN1943669A (en) | The Chinese traditional medicinal preparation for treatment of calculus | |
| CN1255130C (en) | Chinese traditional medicine for treating pruritus | |
| CN1327886C (en) | Pharmaceutical composition for treating arthritis and method for preparing the same | |
| CN101411819A (en) | Chinese medicinal composition for treating hepatitis B | |
| CN1158095C (en) | Chinese medicine for treating rheumatoid arthritis | |
| CN1238964A (en) | 'Linduling' for treating gonorrhoea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |